Symbols / ZIVO
ZIVO Chart
About
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 36.40M |
| Enterprise Value | 38.68M | Income | -8.49M | Sales | 209.03K |
| Book/sh | -0.86 | Cash/sh | 0.01 | Dividend Yield | — |
| Payout | 0.00% | Employees | 7 | IPO | — |
| P/E | — | Forward P/E | -7.80 | PEG | — |
| P/S | 174.13 | P/B | -10.91 | P/C | — |
| EV/EBITDA | — | EV/Sales | 185.03 | Quick Ratio | 0.02 |
| Current Ratio | 0.08 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -2.18 | EPS next Y | -1.20 | EPS Growth | — |
| Revenue Growth | 108.30% | Earnings | 2025-11-14 16:00 | ROA | -10.02% |
| ROE | — | ROIC | — | Gross Margin | 31.67% |
| Oper. Margin | -15.52% | Profit Margin | 0.00% | Shs Outstand | 3.89M |
| Shs Float | 1.94M | Short Float | 2.61% | Short Ratio | 6.65 |
| Short Interest | — | 52W High | 21.00 | 52W Low | 6.95 |
| Beta | 0.22 | Avg Volume | 1.06K | Volume | 175.00 |
| Target Price | — | Recom | None | Prev Close | $9.75 |
| Price | $9.36 | Change | -4.00% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$9.36
Latest analyst target
3. DCF / Fair value
$-12.12
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$9.36
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-06-04 | down | Maxim Group | Buy → Hold | — |
- Strome investment buys Zivo Bioscience (ZIVO) shares worth $195k By Investing.com - Investing.com ue, 17 Feb 2026 12
- Insider Stock Purchases: February 17, 2026 - Quiver Quantitative ue, 17 Feb 2026 18
- Zivo Bioscience Director Makes Bold Insider Move With Fresh Stock Purchase - TipRanks Fri, 13 Feb 2026 11
- Zivo Bioscience CFO Resigns, Interim Successor Appointed - The Globe and Mail Wed, 24 Dec 2025 08
- Insider Buying: Alison Cornell Acquires Additional Shares of Ziv - GuruFocus hu, 29 Jan 2026 00
- Major Investor Quietly Expands Stake in Zivo Bioscience - TipRanks Wed, 18 Feb 2026 02
- Yaldoo Laith L buys Zivo Bioscience (ZIVO) shares worth $14,993 - Investing.com ue, 27 Jan 2026 08
- Two Zivo Bioscience Insiders Make Matching Moves That Signal Growing Confidence - TipRanks ue, 27 Jan 2026 08
- Director and 10% Owner Christopher Maggiore Acquires 31,336 Shares of Zivo Bioscience Inc (ZIVO) - Yahoo Finance Fri, 23 Aug 2024 07
- Zivo Bioscience Advances Breakthrough Poultry Treatment, Major Licensing Deal Expected Q1 2025 - Stock Titan Mon, 23 Dec 2024 08
- Pricey consumer staples stocks with halting momentum - low momentum and high valuation (BRBR:NYSE) - Seeking Alpha ue, 03 Feb 2026 08
- Cash infusion keeps algae firm Zivo Bioscience afloat during development voyage - NutraIngredients.com hu, 19 Aug 2021 07
- Adam Zivo: Zelenskyy’s closest ally resigns amid deepening corruption scandal - MSN Wed, 03 Dec 2025 12
- United States Stocks at New 52-Week Lows Today February 2026 - Meyka hu, 05 Jun 2025 12
- Maggiore buys Zivo Bioscience shares worth $14,993 - Investing.com ue, 27 Jan 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 20000 | 195400.0 | — | Purchase at price 9.77 per share. | STROME MARK E. | Beneficial Owner of more than 10% of a Class of Security | — | 2026-02-12 00:00:00 | I |
| 1 | 2434 | 24997.0 | — | Purchase at price 10.27 per share. | YALDOO LAITH | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2026-02-10 00:00:00 | I |
| 2 | 11709 | 99995.0 | — | Purchase at price 8.54 per share. | CORNELL ALISON A | Director | — | 2026-01-26 00:00:00 | D |
| 3 | 11709 | 99995.0 | — | Purchase at price 8.54 per share. | PAYNE JOHN BERNARD | Chief Executive Officer | — | 2026-01-26 00:00:00 | D |
| 4 | 1766 | 14993.0 | — | Purchase at price 8.49 per share. | MAGGIORE CHRISTOPHER D | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2026-01-14 00:00:00 | D |
| 5 | 1766 | 14993.0 | — | Purchase at price 8.49 per share. | YALDOO LAITH | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2026-01-14 00:00:00 | I |
| 6 | 2777 | 24993.0 | — | Purchase at price 9.00 per share. | YALDOO LAITH | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2025-11-28 00:00:00 | I |
| 7 | 20259 | 249996.0 | — | Purchase at price 12.34 per share. | STROME MARK E. | Beneficial Owner of more than 10% of a Class of Security | — | 2025-10-13 00:00:00 | I |
| 8 | 1659 | 19991.0 | — | Purchase at price 12.05 per share. | YALDOO LAITH | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2025-10-10 00:00:00 | I |
| 9 | 23682 | 284421.0 | — | Purchase at price 12.01 per share. | MAGGIORE CHRISTOPHER D | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2025-10-08 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -13.36M | -7.26M | -8.73M | -8.65M |
| TotalUnusualItems | 0.00 | 122.52K | ||
| TotalUnusualItemsExcludingGoodwill | 0.00 | 122.52K | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | -13.38M | -7.78M | -8.75M | -8.76M |
| ReconciledCostOfRevenue | 108.27K | 16.04K | 0.00 | |
| EBITDA | -13.36M | -7.26M | -8.73M | -8.52M |
| EBIT | -13.36M | -7.26M | -8.73M | -8.52M |
| NetInterestIncome | -22.94K | -514.17K | -13.32K | -233.28K |
| InterestExpense | 22.94K | 514.17K | 13.32K | 233.28K |
| NormalizedIncome | -13.38M | -7.78M | -8.75M | -8.88M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -13.38M | -7.78M | -8.75M | -8.76M |
| TotalExpenses | 13.52M | 7.29M | 8.73M | 8.65M |
| TotalOperatingIncomeAsReported | -13.36M | -7.26M | -8.73M | -8.65M |
| DilutedAverageShares | 3.17M | 1.69M | 1.57M | 1.27M |
| BasicAverageShares | 3.17M | 1.69M | 1.57M | 1.27M |
| DilutedEPS | -4.23 | -4.60 | -5.57 | -6.90 |
| BasicEPS | -4.23 | -4.60 | -5.57 | -6.90 |
| DilutedNIAvailtoComStockholders | -13.38M | -7.78M | -8.75M | -8.76M |
| NetIncomeCommonStockholders | -13.38M | -7.78M | -8.75M | -8.76M |
| NetIncome | -13.38M | -7.78M | -8.75M | -8.76M |
| NetIncomeIncludingNoncontrollingInterests | -13.38M | -7.78M | -8.75M | -8.76M |
| NetIncomeContinuousOperations | -13.38M | -7.78M | -8.75M | -8.76M |
| PretaxIncome | -13.38M | -7.78M | -8.75M | -8.76M |
| OtherIncomeExpense | 122.52K | |||
| SpecialIncomeCharges | 0.00 | 122.52K | ||
| OtherSpecialCharges | -122.52K | |||
| NetNonOperatingInterestIncomeExpense | -22.94K | -514.17K | -13.32K | -233.28K |
| InterestExpenseNonOperating | 22.94K | 514.17K | 13.32K | 233.28K |
| OperatingIncome | -13.36M | -7.26M | -8.73M | -8.65M |
| OperatingExpense | 13.41M | 7.27M | 8.73M | 8.65M |
| ResearchAndDevelopment | 3.13M | 1.38M | 2.24M | 1.95M |
| SellingGeneralAndAdministration | 10.28M | 5.90M | 6.49M | 6.69M |
| GeneralAndAdministrativeExpense | 10.28M | 5.90M | 6.49M | 6.69M |
| OtherGandA | 10.28M | 5.90M | 6.49M | 6.69M |
| GrossProfit | 48.95K | 11.61K | 0.00 | |
| CostOfRevenue | 108.27K | 16.04K | 0.00 | |
| TotalRevenue | 157.22K | 27.65K | 0.00 | 0.00 |
| OperatingRevenue | 157.22K | 27.65K | 0.00 | 0.00 |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 3.62M | 2.38M | 1.57M | 1.57M |
| ShareIssued | 3.62M | 2.38M | 1.57M | 1.57M |
| TotalDebt | 254.36K | 346.34K | 445.18K | 255.18K |
| TangibleBookValue | -514.90K | -2.21M | -10.62K | 6.04M |
| InvestedCapital | -260.54K | -1.97M | 229.38K | 6.28M |
| WorkingCapital | -406.38K | -2.34M | -126.04K | 6.01M |
| NetTangibleAssets | -514.90K | -2.21M | -10.62K | 6.04M |
| CapitalLeaseObligations | 0.00 | 106.34K | 205.18K | 15.18K |
| CommonStockEquity | -514.90K | -2.21M | -10.62K | 6.04M |
| TotalCapitalization | -398.70K | -2.21M | -10.62K | 6.04M |
| TotalEquityGrossMinorityInterest | -514.90K | -2.21M | -10.62K | 6.04M |
| StockholdersEquity | -514.90K | -2.21M | -10.62K | 6.04M |
| RetainedEarnings | -136.97M | -123.58M | -115.80M | -107.06M |
| AdditionalPaidInCapital | 136.45M | 121.37M | 115.79M | 113.09M |
| CapitalStock | 3.62K | 2.38K | 1.57K | 9.42K |
| CommonStock | 3.62K | 2.38K | 1.57K | 9.42K |
| TotalLiabilitiesNetMinorityInterest | 2.16M | 2.76M | 2.13M | 2.95M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 116.20K | 0.00 | 105.92K | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 116.20K | 0.00 | 105.92K | 0.00 |
| LongTermCapitalLeaseObligation | 0.00 | 105.92K | 0.00 | |
| LongTermDebt | 116.20K | |||
| CurrentLiabilities | 2.04M | 2.76M | 2.03M | 2.95M |
| CurrentDeferredLiabilities | 0.00 | 701.33K | 1.48M | |
| CurrentDebtAndCapitalLeaseObligation | 138.16K | 346.34K | 339.26K | 255.18K |
| CurrentCapitalLeaseObligation | 0.00 | 106.34K | 99.26K | 15.18K |
| CurrentDebt | 138.16K | 240.00K | 240.00K | 240.00K |
| OtherCurrentBorrowings | 138.16K | 240.00K | 240.00K | 240.00K |
| PensionandOtherPostRetirementBenefitPlansCurrent | 1.10M | 1.15M | 398.18K | 467.21K |
| PayablesAndAccruedExpenses | 807.48K | 1.27M | 588.96K | 750.22K |
| CurrentAccruedExpenses | 65.63K | 100.69K | 98.29K | 95.89K |
| InterestPayable | 65.63K | 100.69K | 98.29K | 95.89K |
| Payables | 741.85K | 1.17M | 490.67K | 654.33K |
| DuetoRelatedPartiesCurrent | 194.76K | 172.67K | 0.00 | |
| AccountsPayable | 547.09K | 993.09K | 490.67K | 654.33K |
| TotalAssets | 1.64M | 555.72K | 2.12M | 8.99M |
| TotalNonCurrentAssets | 7.68K | 130.34K | 221.34K | 30.23K |
| NonCurrentPrepaidAssets | 7.68K | 32.06K | 32.06K | 3.00K |
| NetPPE | 0.00 | 98.28K | 189.28K | 27.23K |
| AccumulatedDepreciation | -100.00K | |||
| GrossPPE | 0.00 | 98.28K | 189.28K | 27.23K |
| OtherProperties | 98.28K | 189.28K | 27.23K | |
| MachineryFurnitureEquipment | 20.00K | |||
| CurrentAssets | 1.64M | 425.38K | 1.90M | 8.96M |
| PrepaidAssets | 90.79K | 147.26K | 102.42K | 58.08K |
| Receivables | 2.21K | 3.73K | 0.00 | |
| AccountsReceivable | 2.21K | 3.73K | 0.00 | |
| GrossAccountsReceivable | 3.73K | 0.00 | ||
| CashCashEquivalentsAndShortTermInvestments | 1.54M | 274.38K | 1.80M | 8.90M |
| CashAndCashEquivalents | 1.54M | 274.38K | 1.80M | 8.90M |
| CashFinancial | 1.54M | 274.38K | 1.80M | 8.90M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -4.31M | -5.80M | -7.10M | -6.80M |
| RepaymentOfDebt | -538.26K | -1.76M | -628.60K | -190.50K |
| IssuanceOfDebt | 517.56K | 1.76M | 628.60K | 190.50K |
| IssuanceOfCapitalStock | 5.60M | 640.00K | 0.00 | 17.21M |
| InterestPaidSupplementalData | 18.95K | 72.18K | 10.92K | 3.08K |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 | 0.00 |
| EndCashPosition | 1.54M | 274.38K | 1.80M | 8.90M |
| BeginningCashPosition | 274.38K | 1.80M | 8.90M | 137.86K |
| ChangesInCash | 1.27M | -1.52M | -7.10M | 8.76M |
| FinancingCashFlow | 5.58M | 4.28M | 0.00 | 15.57M |
| CashFlowFromContinuingFinancingActivities | 5.58M | 4.28M | 0.00 | 15.57M |
| NetOtherFinancingCharges | -1.70M | |||
| ProceedsFromStockOptionExercised | 0.00 | 3.64M | 0.00 | 55.70K |
| NetCommonStockIssuance | 5.60M | 640.00K | 0.00 | 17.21M |
| CommonStockIssuance | 5.60M | 640.00K | 0.00 | 17.21M |
| NetIssuancePaymentsOfDebt | -20.70K | 0.00 | 0.00 | 0.00 |
| NetShortTermDebtIssuance | 0.00 | 0.00 | ||
| ShortTermDebtPayments | -1.76M | -628.60K | ||
| ShortTermDebtIssuance | 1.76M | 628.60K | ||
| NetLongTermDebtIssuance | -20.70K | 0.00 | 0.00 | 0.00 |
| LongTermDebtPayments | -538.26K | -1.76M | -628.60K | -190.50K |
| LongTermDebtIssuance | 517.56K | 1.76M | 628.60K | 190.50K |
| InvestingCashFlow | 0.00 | 0.00 | 0.00 | 0.00 |
| OperatingCashFlow | -4.31M | -5.80M | -7.10M | -6.80M |
| CashFlowFromContinuingOperatingActivities | -4.31M | -5.80M | -7.10M | -6.80M |
| ChangeInWorkingCapital | -500.47K | 1.28M | -355.39K | -394.13K |
| ChangeInOtherWorkingCapital | 85.30K | |||
| ChangeInOtherCurrentLiabilities | -106.34K | -98.83K | -51.70K | -29.17K |
| ChangeInPayablesAndAccruedExpense | -476.50K | 1.43M | -230.30K | -422.13K |
| ChangeInAccruedExpense | -52.59K | 752.99K | -66.64K | 483.16K |
| ChangeInPayable | -423.91K | 675.09K | -163.66K | -905.29K |
| ChangeInAccountPayable | -423.91K | 675.09K | -163.66K | -905.29K |
| ChangeInPrepaidAssets | 80.85K | -44.85K | -73.40K | -28.12K |
| ChangeInReceivables | 1.52K | -3.73K | 0.00 | |
| ChangesInAccountReceivables | 1.52K | -3.73K | 0.00 | |
| OtherNonCashItems | 98.28K | -170.74K | -694.39K | -500.83K |
| StockBasedCompensation | 9.47M | 867.36K | 2.69M | 2.97M |
| OperatingGainsLosses | -122.52K | |||
| GainLossOnInvestmentSecurities | 32.77K | |||
| NetIncomeFromContinuingOperations | -13.38M | -7.78M | -8.75M | -8.76M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ZIVO
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|